Sarah K. Bergren

2.0k total citations
12 papers, 860 citations indexed

About

Sarah K. Bergren is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Sarah K. Bergren has authored 12 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Sarah K. Bergren's work include Prostate Cancer Treatment and Research (6 papers), Genetics and Neurodevelopmental Disorders (3 papers) and Genomics and Rare Diseases (2 papers). Sarah K. Bergren is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Genetics and Neurodevelopmental Disorders (3 papers) and Genomics and Rare Diseases (2 papers). Sarah K. Bergren collaborates with scholars based in United States, France and Belgium. Sarah K. Bergren's co-authors include Michael M. Shen, Zhu A. Wang, Roxanne Toivanen, Antonina Mitrofanova, Andrea Califano, Cory Abate‐Shen, Robert D. Cardiff, Jennifer A. Kearney, Hanina Hibshoosh and Chee Wai Chua and has published in prestigious journals such as Nature Communications, Nature Cell Biology and Cancer Research.

In The Last Decade

Sarah K. Bergren

12 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah K. Bergren United States 10 439 367 292 168 95 12 860
Virginia Yao United States 4 538 1.2× 169 0.5× 244 0.8× 209 1.2× 49 0.5× 4 870
Lucía Fanlo Spain 9 634 1.4× 119 0.3× 309 1.1× 214 1.3× 51 0.5× 10 919
Kaishi Satomi Japan 17 274 0.6× 302 0.8× 188 0.6× 139 0.8× 31 0.3× 76 978
Laurent Pelletier France 16 292 0.7× 171 0.5× 88 0.3× 164 1.0× 39 0.4× 27 690
Kathy Astrahantseff Germany 17 645 1.5× 84 0.2× 308 1.1× 383 2.3× 84 0.9× 36 1.2k
Anna F. Lee Canada 16 433 1.0× 384 1.0× 279 1.0× 96 0.6× 37 0.4× 44 1.1k
Stephen H. Settle United States 15 470 1.1× 346 0.9× 310 1.1× 145 0.9× 201 2.1× 25 1.2k
Brett Schroeder United States 13 243 0.6× 169 0.5× 185 0.6× 78 0.5× 43 0.5× 40 582
Gabriele Jaques Germany 19 609 1.4× 131 0.4× 360 1.2× 204 1.2× 71 0.7× 40 1.1k
Julie Lejeune France 18 543 1.2× 415 1.1× 171 0.6× 394 2.3× 30 0.3× 33 1.5k

Countries citing papers authored by Sarah K. Bergren

Since Specialization
Citations

This map shows the geographic impact of Sarah K. Bergren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah K. Bergren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah K. Bergren more than expected).

Fields of papers citing papers by Sarah K. Bergren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah K. Bergren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah K. Bergren. The network helps show where Sarah K. Bergren may publish in the future.

Co-authorship network of co-authors of Sarah K. Bergren

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah K. Bergren. A scholar is included among the top collaborators of Sarah K. Bergren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah K. Bergren. Sarah K. Bergren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bowen, Cai, Maho Shibata, Hailan Zhang, et al.. (2020). CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss. Cancer Research. 80(21). 4805–4814. 2 indexed citations
2.
Hanoun, Maher, Anna Arnal Estape, Maria Maryanovich, et al.. (2019). Nestin+NG2+ Cells Form a Reserve Stem Cell Population in the Mouse Prostate. Stem Cell Reports. 12(6). 1201–1211. 9 indexed citations
3.
Chua, Chee Wai, Nusrat J Epsi, Eva Leung, et al.. (2018). Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation. eLife. 7. 33 indexed citations
4.
Talos, Flaminia, Antonina Mitrofanova, Sarah K. Bergren, Andrea Califano, & Michael M. Shen. (2017). A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue. Nature Communications. 8(1). 14662–14662. 25 indexed citations
5.
Chua, Chee Wai, Maho Shibata, Ming Lei, et al.. (2014). Single luminal epithelial progenitors can generate prostate organoids in culture. Nature Cell Biology. 16(10). 951–961. 268 indexed citations
6.
Wang, Zhu A., Roxanne Toivanen, Sarah K. Bergren, Pierre Chambon, & Michael M. Shen. (2014). Luminal Cells Are Favored as the Cell of Origin for Prostate Cancer. Cell Reports. 8(5). 1339–1346. 106 indexed citations
7.
Wang, Zhu A., Antonina Mitrofanova, Sarah K. Bergren, et al.. (2013). Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nature Cell Biology. 15(3). 274–283. 243 indexed citations
8.
Bergren, Sarah K., et al.. (2009). Fine mapping of an epilepsy modifier gene on mouse Chromosome 19. Mammalian Genome. 20(6). 359–366. 26 indexed citations
9.
Howell, Viive M., Gerald de Haan, Sarah K. Bergren, et al.. (2008). A Targeted Deleterious Allele of the Splicing Factor SCNM1 in the Mouse. Genetics. 180(3). 1419–1427. 8 indexed citations
10.
Howell, Viive M., Julie Jones, Sarah K. Bergren, et al.. (2007). Evidence for a direct role of the disease modifier SCNM1 in splicing. Human Molecular Genetics. 16(20). 2506–2516. 35 indexed citations
11.
Kearney, Jennifer A., Yan Yang, Barbara Beyer, et al.. (2006). Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2. Human Molecular Genetics. 15(6). 1043–1048. 55 indexed citations
12.
Bergren, Sarah K., Shu Chen, Andrzej T. Gałecki, & Jennifer A. Kearney. (2005). Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channelScn2a. Mammalian Genome. 16(9). 683–690. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Yao Breakdown of academic impact, for papers by Lucía Fanlo Breakdown of academic impact, for papers by Kaishi Satomi Breakdown of academic impact, for papers by Laurent Pelletier Breakdown of academic impact, for papers by Kathy Astrahantseff Breakdown of academic impact, for papers by Anna F. Lee Breakdown of academic impact, for papers by Stephen H. Settle Breakdown of academic impact, for papers by Brett Schroeder Breakdown of academic impact, for papers by Gabriele Jaques Breakdown of academic impact, for papers by Julie Lejeune
Rankless by CCL
2026